8:45

1

Otto

Identification of Critical N-Myc Target Genes by an RNA Interference Screen

9:00

2

Valsesia-Wittmann

Neuroblastoma Tumour Cells Escape from N-Myc-Dependent Programmed Cell Death by Upregulating H-Twist, an N-Myc Target Gene

9:15

3

Marshall

Mechanisms of MycN-Mediated Neuroblastoma Tumour Initiation

9:30

4

Slack

Genomic Instability in Neuroblastoma: A Mechanism for MYCN-Mediated Centrosome Hyper-Amplification

9:45

5

Yang

Novel Tumor Suppressor Gene, hCas, Inhibits Neuroblastoma Tumorigenicity

10:00

Break

10:15

6

Isogai

Constitutively Activated [italic]Mash1[/italic] Expression in Aggressive Neuroblastoma Is Regulated by the Oncogenic LMO3 and HEN2 through Inhibiting HES1 Function

10:30

7

Geerts

The MEIS Homeobox Oncogenes Are Involved in Neuroblastoma Cell Cycle Progress and Differentiation

10:45

8

Oberthuer

Gene-Expression Based Classification of Neuroblastoma Patients Using a Customized Oligonucleotide-Microarray Outperforms Current Clinical Risk Stratification

11:00

9

Janoueix-Lerosey

Characterization of Genomic Profiles of Neuroblastoma Samples Using Array-CGH: Supervised and Unsupervised Analysis To Define Clinico-Genetic Subgroups

12:00

Lunch